Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Transplant Outcomes of 9/10 HLA Matched Unrelated Donors (MUD) Treated with Post-Transplant Cyclophosphamide for Prevention of Graft Versus Host Disease

Sai Ravi Pingali, MD, Denai Milton, MS, Uday R. Popat, MD, Chitra M. Hosing, Qaiser Bashir, Amin M. Alousi, MD, Roy Jones, Yago Nieto, Partow Kebriaei, Muzaffar H. Qazilbash, MD, Borje S Andersson, MD PhD, Elizabeth J Shpall, MD, Issa F. Khouri, MD, Richard E. Champlin, Stefan O. Ciurea, MD

Blood (2014) 124 (21): 2486.

https://doi.org/10.1182/blood.V124.21.2486.2486

Published: 2014

Journal Articles

Effect of Timing and Duration of Maintenance Lenalidomide in Myeloma Patients after Autologous Stem Cell Transplantations

Idrees Mian, MD, Denai Milton, MS, Uday R. Popat, MD, Nina Shah, Yago Nieto, Partow Kebriaei, Simrit Parmar, Sairah Ahmed, MD, Jatin J. Shah, Robert Z. Orlowski, MD, PhD, Muzaffar H. Qazilbash, MD, Qaiser Bashir, Richard E. Champlin

Blood (2014) 124 (21): 194.

https://doi.org/10.1182/blood.V124.21.194.194

Published: 2014

Journal Articles

The Effect Of CMV Reactivation On Relapse and Survival In Patients With AML and MDS After Allogeneic Stem Cell Transplant (allo-HCT)

Armin Ghobadi, MD, Amir Hamdi, MD, Piyanuch Kongtim, MD, Denai Milton, Amin Alousi, MD, Paolo Anderlini, MD, Stefan O. Ciurea, MD, Betul Oran, MD, Issa Khouri, MD, Simrit Parmar, MD, Muzaffar H. Qazilbash, MD, Partow Kebriaei, MD, Uday R Popat, MD, Katy Rezvani, MD, PhD, Roy F Chemaly, MD, MPH, Elizabeth J Shpall, MD, Richard E Champlin, MD, Qaiser Bashir, MD

Blood (2013) 122 (21): 4531.

https://doi.org/10.1182/blood.V122.21.4531.4531

Published: 2013

Journal Articles

Transplant Outcomes For Patients With AML/MDS Using Melphalan-Based Conditioning

Blood (2013) 122 (21): 2167.

https://doi.org/10.1182/blood.V122.21.2167.2167

Published: 2013

Journal Articles

Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation

Antonio Di Stasi, Michelle Poon, Amir Hamdi, Hila Shaim, Susan Xie, Denai Milton, Roland Bassett, Gabriela Rondon, Elizabeth J. Shpall, Laurence Cooper, Dean Lee, Katy Rezvani, Richard E. Champlin, Stefan O. Ciurea

Blood (2012) 120 (21): 4485.

https://doi.org/10.1182/blood.V120.21.4485.4485

Published: 2012

NARROW

Transplant Outcomes of 9/10 HLA Matched Unrelated Donors (MUD) Treated with Post-Transplant Cyclophosphamide for Prevention of Graft Versus Host Disease

Effect of Timing and Duration of Maintenance Lenalidomide in Myeloma Patients after Autologous Stem Cell Transplantations

The Effect Of CMV Reactivation On Relapse and Survival In Patients With AML and MDS After Allogeneic Stem Cell Transplant (allo-HCT)

Transplant Outcomes For Patients With AML/MDS Using Melphalan-Based Conditioning

Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Transplant Outcomes of 9/10 HLA Matched Unrelated Donors (MUD) Treated with Post-Transplant Cyclophosphamide for Prevention of Graft Versus Host Disease

Effect of Timing and Duration of Maintenance Lenalidomide in Myeloma Patients after Autologous Stem Cell Transplantations

The Effect Of CMV Reactivation On Relapse and Survival In Patients With AML and MDS After Allogeneic Stem Cell Transplant (allo-HCT)

Transplant Outcomes For Patients With AML/MDS Using Melphalan-Based Conditioning

Reconstitution of Lymphocyte Subsets and Outcomes After Matched and Mismatched Hematopoietic Stem-Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only